| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
207,061,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Evista Holdings is a provider of products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, as well as to improve the aesthetics of the human smile. Co. provides dental implants, orthodontic appliances, general dental consumables, equipment and services. Co.'s segments are: Specialty Products and Technologies, which develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products; and Equipment and Consumables, which develops, manufactures and markets dental equipment and supplies used in dental offices.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
54,532 |
73,717 |
| Total Buy Value |
$0 |
$0 |
$906,708 |
$1,323,786 |
| Total People Bought |
0 |
0 |
2 |
6 |
| Total Buy Transactions |
0 |
0 |
2 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-03-27 |
2024-12-24 |
2024-06-25 |
2023-06-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Raskas Daniel |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,450 |
44,680 |
|
- |
|
| Carruthers Wendy |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,450 |
50,610 |
|
- |
|
| Hulit Barbara B. |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,450 |
79,820 |
|
- |
|
| Tsingos Christine A |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,450 |
50,600 |
|
- |
|
| Huennekens R Scott |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
14,370 |
69,520 |
|
- |
|
| Jain Vivek |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,450 |
43,615 |
|
- |
|
| Gallahue Kieran |
Director |
– • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
10,450 |
44,680 |
|
- |
|
| Keel Paul A |
Chief Executive Officer |
• • – |
2025-05-25 |
4 |
D |
$16.72 |
$213,799 |
D/D |
(12,787) |
401,652 |
|
- |
|
| Reis Mischa |
SVP, Strategy & Bus. Dev. |
• – – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,475 |
47,382 |
|
- |
|
| Hammes Eric D. |
Chief Financial Officer |
• – – |
2025-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
15,735 |
104,442 |
|
- |
|
| Acurio Veronica |
President, Orthodontics |
• – – |
2025-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,290 |
55,745 |
|
- |
|
| Befidi Robert |
President, Diagnostics |
• – – |
2025-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,290 |
48,958 |
|
- |
|
| Befidi Robert |
President, Diagnostics |
• – – |
2025-02-25 |
4 |
D |
$20.66 |
$23,201 |
D/D |
(1,123) |
38,668 |
|
- |
|
| Keel Paul A |
Chief Executive Officer |
• • – |
2025-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
65,830 |
414,439 |
|
- |
|
| Nilsson Stefan |
President, Nobel Biocare |
• – – |
2025-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,290 |
55,745 |
|
- |
|
| Nance Mark E |
General Counsel |
• – – |
2025-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
18,155 |
71,945 |
|
- |
|
| Nance Mark E |
General Counsel |
• – – |
2025-02-25 |
4 |
D |
$20.66 |
$76,256 |
D/D |
(3,691) |
53,790 |
|
- |
|
| Kaabi Faez C |
Chief Accounting Officer |
• – – |
2025-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,685 |
49,996 |
|
- |
|
| Kaabi Faez C |
Chief Accounting Officer |
• – – |
2025-02-25 |
4 |
D |
$20.66 |
$89,231 |
D/D |
(4,319) |
40,311 |
|
- |
|
| Reis Mischa |
SVP, Strategy & Bus. Dev. |
• – – |
2025-02-25 |
4 |
D |
$20.66 |
$78,777 |
D/D |
(3,813) |
38,907 |
|
- |
|
| Nilsson Stefan |
President, Nobel BiocareOffice |
• – – |
2024-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,455 |
|
- |
|
| Acurio Veronica |
President, OrthodonticsOfficer |
• – – |
2024-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,455 |
|
- |
|
| Keel Paul A |
Chief Executive Officer |
• • – |
2024-11-01 |
4 |
D |
$20.94 |
$1,130,676 |
D/D |
(53,996) |
348,609 |
|
- |
|
| Reis Mischa |
SVP, Strategy & Bus. Dev. |
• – – |
2024-09-17 |
4 |
D |
$19.00 |
$15,428 |
D/D |
(812) |
42,720 |
|
- |
|
| Befidi Robert |
President, Diagnostics |
• – – |
2024-08-25 |
4 |
D |
$18.70 |
$64,590 |
D/D |
(3,454) |
39,791 |
|
- |
|
291 Records found
|
|
Page 1 of 12 |
|
|
